Productive Value of Sonographic Measurement of Optic Nerve in Transitional Multiple
Launched by ASSIUT UNIVERSITY · May 29, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Multiple sclerosis (MS) is one of the leading disabling neurological diseases in young Adults. Characteristically reliable biomarkers for every independent MS pathogenic factor are extremely important.
1 Increasing evidence has demonstrated that neuronal and axonal damage within the central nervous system (CNS) contributes substantially to the development of permanent disability in patients with MS
* 2 Thus, reliable, economic and easily assessable complementary surrogate biomarkers for axonal Degeneration and consequently disability remain to be identified
* 3 The optic nerve can serve a...
Gender
ALL
Eligibility criteria
- • 1. inclusion criteria
- • 1. both sex
- • 2. Age group from 15 to 50 yrs
- • 3. Patient with RRMS without history of optic neuritis
- 2. Exclusion criteria :
- • 1. History of previous optic neuritis
- • 2. Medical illness of eye(e.g. diabetes and hypertension)
- • 3. MS patient on fingolimod for 6 months or more
- • 4. Relapsing or use of steroid in the past 3 months
- • 5. Proved alternative diagnosis (neuromyelitis optica )
- • 6. local eye disease or surgery
Trial Officials
Anwar M Ali, professor
Study Director
Assiut University
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0